CNBC's Deidre Bosa joins 'The Exchange' to report on the latest drama in 23andMe..
Health
23andMe faces Nasdaq delisting after its entire board resigns
CNBC's Deidre Bosa joins 'The Exchange' to report on the latest drama in 23andMe.